Pressemitteilung: Fujirebio Enhances Supply Chain Operations with Kinaxis

Japanese biotech leader adopts orchestration to more rapidly respond to demand fluctuations / OTTAWA, Ontario--(BUSINESS WIRE)-- Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Fujirebio Inc., a Japanese multinational biotechnology company, is using Kinaxis and its AI-powered supply chain orchestration platform Maestro™ to enhance and optimize its supply chain operations. Fujirebio Inc., a consolidated subsidiary of Fujirebio Holdings Inc., is a global leader in the development, manufacturing and sales of clinical diagnostic reagents and testing equipment. Fujirebio is currently focused on strengthening and expanding its Contract Development and Manufacturing Organization (CDMO) by leveraging high-quality raw materials in the immunology field and advanced reagent development technologies. (....)

Der vollständige Inhalt dieser Pressemitteilung wird auf unserer Seite nicht angezeigt.
Zum Lesen der Mitteilung klicken Sie bitte auf den folgenden Link:

-> Pressemitteilung: Fujirebio Enhances Supply Chain Operations with Kinaxis

Quelle: Kinaxis Inc.

Stichwörter: Kinaxis Inc., Fujirebio, demand fluctuations, end-to-end supply chain orchestration, Japanese, orchestration platform Maestro™, Contract Development and Manufacturing Organization (CDMO)

Kategorie(n): Geschäftsmodelle & Strategien